Leila Rouhi

553 total citations
28 papers, 379 citations indexed

About

Leila Rouhi is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Leila Rouhi has authored 28 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 9 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Leila Rouhi's work include Cardiovascular Effects of Exercise (7 papers), Cardiomyopathy and Myosin Studies (5 papers) and Tissue Engineering and Regenerative Medicine (4 papers). Leila Rouhi is often cited by papers focused on Cardiovascular Effects of Exercise (7 papers), Cardiomyopathy and Myosin Studies (5 papers) and Tissue Engineering and Regenerative Medicine (4 papers). Leila Rouhi collaborates with scholars based in United States, Iran and China. Leila Rouhi's co-authors include Ali J. Marian, Priyatansh Gurha, Sirisha Cheedipudi, Siyang Fan, Matthew J. Robertson, Cristian Coarfa, Zhongming Zhao, Gaëlle Auguste, Melis Olcum and Abdol‐Mohammad Kajbafzadeh and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Leila Rouhi

24 papers receiving 375 citations

Peers

Leila Rouhi
Perry Altman United States
Laura B. Jeffords United States
Guosheng Xiang United States
Indulekha C. L. Pillai India
Elisa Yaniz‐Galende France
Dorota Jeziorowska France
Gregory Emmanuel United States
Konstantina‐Ioanna Sereti United States
Henna Karvinen Finland
Masashi Tamaoki Japan
Perry Altman United States
Leila Rouhi
Citations per year, relative to Leila Rouhi Leila Rouhi (= 1×) peers Perry Altman

Countries citing papers authored by Leila Rouhi

Since Specialization
Citations

This map shows the geographic impact of Leila Rouhi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leila Rouhi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leila Rouhi more than expected).

Fields of papers citing papers by Leila Rouhi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leila Rouhi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leila Rouhi. The network helps show where Leila Rouhi may publish in the future.

Co-authorship network of co-authors of Leila Rouhi

This figure shows the co-authorship network connecting the top 25 collaborators of Leila Rouhi. A scholar is included among the top collaborators of Leila Rouhi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leila Rouhi. Leila Rouhi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rouhi, Leila. (2025). Cardiac phenotypes in LMNA mutations. Current Opinion in Cardiology. 40(3). 131–138.
2.
Rouhi, Leila, Priyatansh Gurha, & Ali J. Marian. (2025). The CGAS-STING1 Pathway as a Mediator of Innate Immune Response in Cardiovascular Disease. JACC Asia. 5(4). 516–527. 2 indexed citations
3.
4.
Olcum, Melis, Siyang Fan, Leila Rouhi, et al.. (2023). Genetic inactivation of β-catenin is salubrious, whereas its activation is deleterious in desmoplakin cardiomyopathy. Cardiovascular Research. 119(17). 2712–2728. 9 indexed citations
5.
Rouhi, Leila, et al.. (2023). Cytosolic DNA sensing protein pathway is activated in human hearts with dilated cardiomyopathy. PubMed. 3(3). 10 indexed citations
6.
Rouhi, Leila. (2023). Every day is an opportunity to learn something new. 3(2). 13–13. 1 indexed citations
7.
8.
Olcum, Melis, Leila Rouhi, Siyang Fan, et al.. (2022). PANoptosis is a prominent feature of desmoplakin cardiomyopathy. PubMed. 3(1). 3–3. 18 indexed citations
9.
10.
Rouhi, Leila, Siyang Fan, Sirisha Cheedipudi, et al.. (2022). Effects of tamoxifen inducible MerCreMer on gene expression in cardiac myocytes in mice. PubMed. 2. 14 indexed citations
11.
Cheedipudi, Sirisha, Siyang Fan, Leila Rouhi, & Ali J. Marian. (2021). Pharmacological suppression of the WNT signaling pathway attenuates age-dependent expression of the phenotype in a mouse model of arrhythmogenic cardiomyopathy. PubMed. 1(3). 6 indexed citations
12.
Rouhi, Leila, Siyang Fan, Sirisha Cheedipudi, et al.. (2021). The EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure. Cardiovascular Research. 118(6). 1466–1478. 32 indexed citations
13.
Auguste, Gaëlle, Leila Rouhi, Scot J. Matkovich, et al.. (2020). BET bromodomain inhibition attenuates cardiac phenotype in myocyte-specific lamin A/C–deficient mice. Journal of Clinical Investigation. 130(9). 4740–4758. 47 indexed citations
14.
Rouhi, Leila, et al.. (2014). The Effect of Ellagic Acid on Memory and Pain Induced by Brain Ischemia in Adult Male Rats. Journal of Advances in Medical and Biomedical Research. 22(92). 33–42. 1 indexed citations
15.
Ferreiro, José Luis, Leila Rouhi, Lucienne Michaux, et al.. (2014). Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-Cell Lymphoma. PLoS ONE. 9(7). e102977–e102977. 35 indexed citations
16.
Rouhi, Leila, José Luis Ferreiro, Thomas Tousseyn, et al.. (2014). Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1. PLoS ONE. 9(1). e85851–e85851. 15 indexed citations
17.
18.
Rouhi, Leila, et al.. (2013). Autologous serum enhances cardiomyocyte differentiation of rat bone marrow mesenchymal stem cells in the presence of transforming growth factor-β1 (TGF-β1). In Vitro Cellular & Developmental Biology - Animal. 49(4). 287–294. 17 indexed citations
19.
Eslaminejad, Mohamadreza Baghaban, et al.. (2009). EXPRESSION OF CONCERN: Rat marrow‐derived mesenchymal stem cells developed in a medium supplemented with the autologous versus bovine serum. Cell Biology International. 33(5). 607–616. 8 indexed citations
20.
Rouhi, Leila, et al.. (2007). CULTURE AND EXPANSION OF RAT MESENCHYMAL STEM CELLS USING THE SERUM PREPARED FROM RAT’S PERIPHERAL BLOOD. 4(17). 331–344. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Perry Altman Breakdown of academic impact, for papers by Laura B. Jeffords Breakdown of academic impact, for papers by Guosheng Xiang Breakdown of academic impact, for papers by Indulekha C. L. Pillai Breakdown of academic impact, for papers by Elisa Yaniz‐Galende Breakdown of academic impact, for papers by Dorota Jeziorowska Breakdown of academic impact, for papers by Gregory Emmanuel Breakdown of academic impact, for papers by Konstantina‐Ioanna Sereti Breakdown of academic impact, for papers by Henna Karvinen Breakdown of academic impact, for papers by Masashi Tamaoki
Rankless by CCL
2026